BACK TO TOP
KSE100
173,636.07
-1692.75
(-0.97%)
KSE100PR
52,494.12
-515.39
(-0.97%)
ALLSHR
105,405.30
-1037.53
(-0.97%)
KSE30
51,703.15
-591.67
(-1.13%)
KMI30
247,520.67
-2718.47
(-1.09%)
BKTI
48,438.84
-634.09
(-1.29%)
OGTI
35,173.31
-596.48
(-1.67%)
KMIALLSHR
68,206.02
-638.20
(-0.93%)
PSXDIV20
79,995.74
-753.59
(-0.93%)
UPP9
61,741.82
-538.34
(-0.86%)
NITPGI
45,916.14
-514.09
(-1.11%)
NBPPGI
49,520.02
-593.10
(-1.18%)
MZNPI
30,842.44
-314.47
(-1.01%)
JSMFI
42,986.14
-1715.11
(-3.84%)
ACI
22,712.53
-246.96
(-1.08%)
JSGBKTI
73,956.84
-707.28
(-0.95%)
HBLTTI
18,992.80
04-09-2026
0.10
(0.00%)
MII30
22,418.50
-191.24
(-0.85%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.72.68
-2.50
(-3.32%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Mon, Sep 7, 2026 3:49 PM
REG
DFC
CSF
ODL
Open
75.77
High
75.77
Low
72.50
Volume
1,370,620
CIRCUIT BREAKER
67.66 — 82.70
DAY RANGE
72.50 — 75.77
52-WEEK RANGE ^
69.25 — 104.25
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
75.18
VAR
12.00
HAIRCUT
15.00
P/E Ratio (TTM) **
15.11
1-Year Change * ^
-24.43%
YTD Change * ^
-14.09%
Last update: Mon, Sep 7, 2026 3:48 PM
Open
75.11
High
75.25
Low
73.07
Close
73.20
Change
-3.62%
LDCP
75.95
Volume
316,000
Total Trades
390
CIRCUIT BREAKER
68.36 — 83.55
DAY RANGE
73.07 — 75.25
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 30, 2026 3:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
77.87
Volume
0
Total Trades
0
CIRCUIT BREAKER
70.08 — 85.66
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 2, 2026 2:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
76.95
Volume
0
Total Trades
0
CIRCUIT BREAKER
69.26 — 84.65
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Jun 28, 2026 3:32 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
75.80
Volume
0
Total Trades
0
CIRCUIT BREAKER
68.22 — 83.38
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,604,560.02
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31 March 2026 View   PDF
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
DateTitleDocument
Aug 28, 2026Notice of Extraordinary General Meeting View   PDF
Jul 9, 2026Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 08 July 2026 View   PDF
Jul 9, 2026Minutes of Extraordinary General Meeting
REVOKED
View   PDF
Jul 1, 2026Board Meeting Other Than Financial Results View   PDF
Jun 15, 2026Notice of Extraordinary General Meeting View   PDF
DateTitleDocument
Aug 10, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 7, 2026Chief Financial Officer View   PDF
Jul 8, 2026Material Information View   PDF
May 21, 2026Material Information View   PDF
May 6, 2026Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,084,7464,332,5663,370,2473,341,108
Profit after Taxation275,415404,334203,691220,375
EPS1.211.770.890.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports